medMS Doctoral Program
The MyLab program is supplemented by a program for medical students: the doctoral program is designed to create incentives for medical students interested in scientific study to focus on the topic of multiple sclerosis in their dissertation and/or enhance the scientific quality of the work.
The main award is a 12-month grant during the practical phase of the doctoral program, in which the study of medicine is interrupted for at least six months to allow full-time work on the dissertation. The doctoral mentor receives funding for equipment. The doctoral candidates supported by the GHS meet regularly (also past the time of the grant) to engage in scientific discussion. In addition, each doctoral candidate can visit the World MS Congress and a neuro-scientific summer school. Outstanding dissertations receive an award.
Non-medication-based MS Therapy
Award of Grants for Scientific Projects for Non-medication-based MS Therapy
In 2018, the Hertie Foundation has announced one-time grants together with a scientific MS consortium of the pharmaceuticals industry (consisting of six companies: Bayer Vital GmbH, Biogen GmbH, Novartis Pharma GmbH, Roche Pharma AG, Sanofi-Genzyme, and TEVA GmbH) for research projects on non-medication-based MS therapy. The focus lies on work that study the impact of non-medication-based factors on multiple sclerosis or very specifically with therapeutic effects of nutrition, sports etc.
- The grants were directed at MS Researchers.
- A maximum of € 100,000 per research project could be applied for.
- The subject matter of the application had to be within the spectrum of non-medication-based MS therapy (nutrition, sports, climate, psychology etc.).
- The Hertie Foundation shouldered the entire operative implementation of the project, incl. organization of the scientific expert opinion, approval of funds, and support of the researchers.